Listen as experts discuss current best practices and emerging approaches for treating patients with myelofibrosis.
In this episode, John Mascarenhas, MD, and Ruben A. Mesa, MD, FACP, discuss current best practices and emerging approaches for treating patients with myelofibrosis, including:
Presenters:
John Mascarenhas, MD
Professor of Medicine
Icahn School of Medicine at Mount Sinai
Director, Adult Leukemia Program
Leader, Myeloproliferative Disorders Clinical Research Program
Division of Hematology/Oncology
Tisch Cancer Institute
New York, New York
Ruben A. Mesa, MD, FACP
Executive Director, Atrium Health Wake Forest Baptist Comprehensive Cancer Center
Enterprise Senior Vice President, Atrium Health
President, Enterprise Cancer Service Line
Vice Dean for Cancer Programs, Wake Forest University School of Medicine
Professor of Medicine, Wake Forest University School of Medicine
Winston-Salem, North Carolina